Analyst Ratings for Unicycive Therapeutics (UNCY)
UNCY Rating Summary
UNCY Price Target Summary
- Highest: $72.00 (WestPark Capital)
- Lowest: $21.00 (Benchmark)
- Average: $44.80
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$44.80 (+579.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$44.80 (+579.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/19/2026 | WestPark Capital | N/A | New Coverage | Buy (N/A) |
72.00 (N/A) |
6.37 (6.59) |
3.45% | Details |
| 6/4/2025 | Lucid Capital Markets » Updated 11/12/2025 |
Elemer Piros | New Coverage | Buy (N/A) |
63.00 (105.00) |
0.76 (6.59) |
767.11% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
